Clinical Trial Update: Phase II Study of Gemcitabine and TS-1 in Biliary Trat Cancer [Phase 2]

View source ↗

Summary

Phase II trial of gemcitabine plus TS-1 for biliary tract cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Samsung Medical Center | Conditions: Biliary Tract Cancer | Phase 2 | Status: TERMINATED